QuidelOrtho Corporation Retention Compensation AgreementRetention Compensation Agreement • August 1st, 2024 • QuidelOrtho Corp • In vitro & in vivo diagnostic substances
QuidelOrtho Corporation (the “Company”) has awarded to you (the “Participant”) a cash retention award in the amount and on the terms set forth below (the “Cash Retention Award”) and has granted you an award of restricted stock units pursuant to the Company’s 2018 Equity Incentive Plan (the “Plan”) and the applicable form of award agreement thereunder (the “Equity Retention Award”). Your Cash Retention Award and Equity Retention Award (collectively, the “Retention Awards”) are subject to all of the terms and conditions as set forth in this Retention Compensation Agreement (this “Agreement”).
